Botond Lakatos
- Co-authors
- István Vályi‐NagyJános SzlávikManuel BattegayBálint Gergely SzabóAndreas F. WidmerReno FreiLuigia ElziIlona Bobek
- Topics
- COVID-19 Clinical Research Studies (16 papers)Long-Term Effects of COVID-19 (11 papers)SARS-CoV-2 and COVID-19 Research (6 papers)
In The Last Decade
Botond Lakatos
46 papers receiving 262 citations
Peers
Comparison fields: 5 of 76
- Infectious Diseases 146
- Epidemiology 84
- Neurology 46
- Oncology 27
- Molecular Biology 22
Countries citing papers authored by Botond Lakatos
This map shows the geographic impact of Botond Lakatos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Botond Lakatos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Botond Lakatos more than expected).
Fields of papers citing papers by Botond Lakatos
This network shows the impact of papers produced by Botond Lakatos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Botond Lakatos. The network helps show where Botond Lakatos may publish in the future.
Co-authorship network of co-authors of Botond Lakatos
This figure shows the co-authorship network connecting the top 25 collaborators of Botond Lakatos. A scholar is included among the top collaborators of Botond Lakatos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Botond Lakatos. Botond Lakatos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 3 | |
| 7 | 2 | |
| 8 | 4 | |
| 9 | 1 | |
| 10 | 0 | |
| 11 | 2 | |
| 12 | 1 | |
| 13 | 14 | |
| 14 | 19 | |
| 15 | Citokinellenes terápia az új típusú koronavírus okozta megbetegedés (COVID–19) kezelésében – tocilizumab elsőként való alkalmazása egy hazai infektológiai osztályon (A COVID–19-pandémia orvosszakmai kérdései) | 6 |
| 16 | 15 | |
| 17 | 11 | |
| 18 | [Neurocognitive impairments of HIV infected individuals -- preliminary results of a national prevalence study in Hungary]. | 3 |
| 19 | 4 | |
| 20 | 23 |
About Botond Lakatos
Botond Lakatos is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases and Virology, having authored 53 papers that have together received 266 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (16 papers), Long-Term Effects of COVID-19 (11 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (17 citations), Infectious Diseases (146 citations) and Virology (22 citations). Botond Lakatos has collaborated with scholars based in Hungary, Romania and Poland. Frequent co-authors include István Vályi‐Nagy, János Szlávik, Manuel Battegay, Bálint Gergely Szabó, Andreas F. Widmer, Reno Frei, Luigia Elzi, Ilona Bobek, Marcel Stoeckle and Catia Marzolini. Their work appears in journals such as PLoS ONE, International Journal of Molecular Sciences and Critical Care Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.